Efficient Gene Transfer into Human CD34 + Cells by a Retargeted Adenovirus Vector
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Efficient infection with adenovirus (Ad) vectors based on serotype 5 (Ad5) requires the presence of coxsackievirus-adenovirus receptors (CAR) and α v integrins on cells. The paucity of these cellular receptors is thought to be a limiting factor for Ad gene transfer into hematopoietic stem cells. In a systematic approach, we screened different Ad serotypes for interaction with noncycling human CD34 + cells and K562 cells on the level of virus attachment, internalization, and replication. From these studies, serotype 35 emerged as the variant with the highest tropism for CD34 + cells. A chimeric vector (Ad5GFP/F35) was generated which contained the short-shafted Ad35 fiber incorporated into an Ad5 capsid. This substitution was sufficient to transplant all infection properties from Ad35 to the chimeric vector. The retargeted, chimeric vector attached to a receptor different from CAR and entered cells by an α v integrin-independent pathway. In transduction studies, Ad5GFP/F35 expressed green fluorescent protein (GFP) in 54% of CD34 + cells. In comparison, the standard Ad5GFP vector conferred GFP expression to only 25% of CD34 + cells. Importantly, Ad5GFP transduction, but not Ad5GFP/F35, was restricted to a specific subset of CD34 + cells expressing α v integrins. The actual transduction efficiency was even higher than 50% because Ad5GFP/F35 viral genomes were found in GFP-negative CD34 + cell fractions, indicating that the cytomegalovirus promoter used for transgene expression was not active in all transduced cells. The chimeric vector allowed for gene transfer into a broader spectrum of CD34 + cells, including subsets with potential stem cell capacity. Fifty-five percent of CD34 + c-Kit + cells expressed GFP after infection with Ad5GFP/F35, whereas only 13% of CD34 + c-Kit + cells were GFP positive after infection with Ad5GFP. These findings represent the basis for studies aimed toward stable gene transfer into hematopoietic stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Tomko, R. P., Xu, R., & Philipson, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3352 · Cited by 1,200
The polypeptides of adenovirus
Maizel, J. V., White, D. O., & Scharff, M. D. (1968) · Virology · doi:10.1016/0042-6822(68)90121-9 · Cited by 884
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
Mittereder, N., March, K. L., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7498-7509.1996 · Cited by 777
Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C. Y., Bhatia, M., Lapidot, T., Moritz, T., Murdoch, B., Xiao, X. L., Kato, I., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1329 · Cited by 726
Roelvink, P. W., Lizonova, A., Lee, J. G. M., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I., & Wickham, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7909-7915.1998 · Cited by 654
Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., & Mehtali, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4805-4810.1996 · Cited by 653
Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
Ikuta, K., & Weissman, I. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1502 · Cited by 636
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., & Curiel, D. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6839-6846.1996 · Cited by 387
Case, S. S., Price, M. A., Jordan, C. T., Yu, X. J., Wang, L., Bauer, G., Haas, D. L., Xu, D., Stripecke, R., Naldini, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2988 · Cited by 386
Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., & Wold, W. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2296-2306.1996 · Cited by 375
Increasing Incidence of Adenovirus Disease in Bone Marrow Transplant Recipients
Flomenberg, P., Babbitt, J., Drobyski, W. R., Ash, R. C., Carrigan, D. R., Sedmak, G. V., McAuliffe, T., Camitta, B., Horowitz, M. M., Bunin, N., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.4.775 · Cited by 355
Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method
Mizuguchi, H., & Kay1, M. A. (1998) · Human Gene Therapy · doi:10.1089/10430349850019418 · Cited by 351
Wickham, T. J., Roelvink, P. W., Brough, D. E., & Kovesdi, I. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1570 · Cited by 326
Krasnykh, V., Dmitriev, I., Mikheeva, G., Miller, C. R., Belousova, N., & Curiel, D. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1844-1852.1998 · Cited by 314
Sánchez, M.-J., Holmes, A., Miles, C., & Dzierzak, E. (1996) · Immunity · doi:10.1016/s1074-7613(00)80267-8 · Cited by 304
Huang, S., Endo, R. I., & Nemerow, G. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2257-2263.1995 · Cited by 289
Wickham, T. J., Segal, D. M., Roelvink, P. W., Carrion, M. E., Lizonova, A., Lee, G. M., & Kovesdi, I. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6831-6838.1996 · Cited by 288
Multiple adenovirus serotypes use alpha v integrins for infection
Mathias, P., Wickham, T., Moore, M., & Nemerow, G. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6811-6814.1994 · Cited by 286
Human adenovirus-host cell interactions: comparative study with members of subgroups B and C
Defer, C., Belin, M. T., Caillet-Boudin, M. L., & Boulanger, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.8.3661-3673.1990 · Cited by 250
Gall, J., Kass-Eisler, A., Leinwand, L., & Falck-Pedersen, E. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2116-2123.1996 · Cited by 239
Huang, S., Kamata, T., Takada, Y., Ruggeri, Z. M., & Nemerow, G. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4502-4508.1996 · Cited by 237
Zabner, J., Freimuth, P., Puga, A., Fabrega, A., & Welsh, M. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119625 · Cited by 222
Lieber, A., He, C. Y., Kirillova, I., & Kay, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8944-8960.1996 · Cited by 211
Self-citationWickham, T. J., Carrion, M. E., & Kovesdi, I. (1995) · PubMed · Cited by 209
Bodine, D., Moritz, T., Donahue, R., Luskey, B., Kessler, S., Martin, D., Orkin, S., Nienhuis, A., & Williams, D. (1993) · Blood · doi:10.1182/blood.v82.7.1975.1975 · Cited by 192
Stevenson, S. C., Rollence, M. L., White, B., Weaver, L., & McClelland, A. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2850-2857.1995 · Cited by 189
Human Adenovirus Vectors for Gene Transfer into Mammalian Cells
Hitt, M. M., Addison, C. L., & Graham, F. L. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60140-4 · Cited by 186
A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses
Hsu, K. H., Lonberg-Holm, K., Alstein, B., & Crowell, R. L. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1647-1652.1988 · Cited by 177
Miyazawa, N., Leopold, P. L., Hackett, N. R., Ferris, B., Worgall, S., Falck-Pedersen, E., & Crystal, R. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6056-6065.1999 · Cited by 157
Adhesion receptor expression by hematopoietic cell lines and murine progenitors
Becker, P. S., Nilsson, S. K., Li, Z., Berrios, V. M., Dooner, M. S., Cooper, C. L., Hsieh, C., & Quesenberry, P. J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00037-x · Cited by 132
Adenovirus Type 5 E4 Open Reading Frame 4 Protein Induces Apoptosis in Transformed Cells
Shtrichman, R., & Kleinberger, T. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2975-2982.1998 · Cited by 131
Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors
Neering, S. J., Hardy, S., Minamoto, D., Spratt, S. K., & Jordan, C. T. (1996) · Blood · doi:10.1182/blood.v88.4.1147.bloodjournal8841147 · Cited by 123
Homing and Trafficking of Hemopoietic Progenitor Cells
Papayannopoulou, T., & Craddock, C. (2009) · Acta Haematologica · doi:10.1159/000203665 · Cited by 115
Self-citationRoberts, A., & Metcalf, D. (1995) · Blood · doi:10.1182/blood.v86.4.1600.bloodjournal8641600 · Cited by 109
Phylogenetic Relationships among Adenovirus Serotypes
Bailey, A., & Mautner, V. (1994) · Virology · doi:10.1006/viro.1994.1664 · Cited by 108
Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells
Crooks, G., & Kohn, D. B. (1993) · Blood · doi:10.1182/blood.v82.11.3290.3290 · Cited by 105
Roelvink, P. W., Kovesdi, I., & Wickham, T. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7614-7621.1996 · Cited by 100
Roy, V., & Verfaillie, C. M. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00031-9 · Cited by 93
Integrating Adenovirus–Adeno-Associated Virus Hybrid Vectors Devoid of All Viral Genes
Lieber, A., Steinwaerder, D. S., Carlson, C. A., & Kay, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9314-9324.1999 · Cited by 91
Self-citationChillón, M., Bosch, A., Zabner, J., Law, L. K., Armentano, D., Welsh, M. J., & Davidson, B. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2537-2540.1999 · Cited by 85
Fiberless Recombinant Adenoviruses: Virus Maturation and Infectivity in the Absence of Fiber
Legrand, V., Spehner, D., Schlesinger, Y., Settelen, N., Pavirani, A., & Mehtali, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.907-919.1999 · Cited by 85
Frey, B. M., Hackett, N. R., Bergelson, J. M., Finberg, R. W., Crystal, R. G., Moore, M. A. S., & Rafii, S. (1998) · Blood · doi:10.1182/blood.v91.8.2781.2781_2781_2792 · Cited by 74
Byk, T., Haddada, H., Vainchenker, W., & Louache, F. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.17-2493 · Cited by 69
Qiu, C., Young, M. B. D., Finn, A. V., & Dichek, D. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.4-507 · Cited by 68
Expression of a foreign epitope on the surface of the adenovirus hexon
Crompton, J. L., Toogood, C. I. A., Wallis, N., & Hay, R. T. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-1-133 · Cited by 68
Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication
Nelson, J. E., & Kay, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8902-8907.1997 · Cited by 67
Chroboczek, J., Ruigrok, R. W. H., & Cusack, S. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79496-4_10 · Cited by 66
Goldman, M., Su, Q., & Wilson, J. M. (1996) · PubMed · Cited by 55
Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination Between Inverted Repeats
Stecher, H., Carlson, C. A., Shayakhmetov, D. M., & Lieber, A. (2003) · Viral Vectors for Gene Therapy · doi:10.1385/1-59259-304-6:135 · Cited by 44
Self-citationGeneration of Adenovirus Vectors Devoid of All Viral Genes by Recombination between Inverted Repeats
Steinwaerder, D. S., Carlson, C. A., & Lieber, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9303-9313.1999 · Cited by 40
Self-citationAdenovirus vectors for gene transduction into mobilized blood CD34+ cells
Bregni, M., Shammah, S., Malaffo, F., Nicola, M. D., Milanesi, M., Magni, M., Matteucci, P., Ravagnani, F., Jordan, C. T., Siena, S., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300620 · Cited by 34
Fiber Gene and Genomic Origin of Human Adenovirus Type 4
Gruber, W. C., Russell, D. J., & Tibbetts, C. (1993) · Virology · doi:10.1006/viro.1993.1516 · Cited by 34
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Scherer, F., Anton, M., Schillinger, U., Henke, J., Bergemann, C., Krüger, A., Gänsbacher, B., & Plank, C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301624 · Cited by 932
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 792
Self-citationAdenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M. K., Greig, J. A., Denby, L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.01.016 · Cited by 643
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Wang, H., Li, Z.-Y., Liu, Y., Persson, J., Beyer, I., Möller, T., Koyuncu, D., Drescher, M. R., Strauss, R., Zhang, X.-B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2270 · Cited by 432
Self-citation
Metadata
- Authors
- Shayakhmetov, D. M., Papayannopoulou, T., Stamatoyannopoulos, G., & Lieber, A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-03-15
- Volume
- 74
- Issue
- 6
- Pages
- 2567-2583
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2162380590
- Cited by
- 367
- References
- 56
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.